Age-related Differences in Plasmalogen Content of Erythrocytes from Patients with the Cerebro-hepato-renal (Zellweger) Syndrome: Implications for Postnatal Detection of the Disease
Overview
Authors
Affiliations
Phosphatidylethanolamine plasmalogen levels were determined in erythrocytes from controls and 13 patients with the cerebro-hepato-renal (Zellweger) syndrome. It was found that in Zellweger patients 20 weeks of age or younger, erythrocyte phosphatidylethanolamine plasmalogen levels were lowered whereas in older patients (except in one) normal levels were found. The results obtained suggest a close relationship between the age of the patients at sampling and the phosphatidylethanolamine plasmalogen levels in their erythrocytes. A possible explanation for these findings and the implications for the postnatal detection of Zellweger syndrome are discussed.
De Biase I, Tortorelli S, Kratz L, Steinberg S, Cusmano-Ozog K, Braverman N Genet Med. 2019; 22(4):686-697.
PMID: 31822849 DOI: 10.1038/s41436-019-0713-9.
Herzog K, Pras-Raves M, Vervaart M, Luyf A, van Kampen A, Wanders R J Lipid Res. 2016; 57(8):1447-54.
PMID: 27284103 PMC: 4959860. DOI: 10.1194/jlr.M067470.
Contribution of fetal MR imaging in the prenatal diagnosis of Zellweger syndrome.
Mochel F, Grebille A, Benachi A, Martinovic J, Razavi F, Rabier D AJNR Am J Neuroradiol. 2006; 27(2):333-6.
PMID: 16484405 PMC: 8148762.
Assay of plasmalogens and polyunsaturated fatty acids (PUFA) in erythrocytes and fibroblasts.
dAcremont G, Vincent G J Inherit Metab Dis. 1995; 18 Suppl 1:84-9.
PMID: 9053558 DOI: 10.1007/BF00711431.
Zellweger syndrome: biochemical procedures in diagnosis, prevention and treatment.
Schutgens R, Wanders R, Heymans H, Schram A, Tager J, Schrakamp G J Inherit Metab Dis. 1987; 10 Suppl 1:33-45.
PMID: 3119940 DOI: 10.1007/BF01812845.